Resolving Clinically Indeterminate Findings During Anal Cancer Surveillance with TTMV-HPV DNA
TTMV-HPV DNA testing reliably clarifies clinically indeterminate findings during ASCC surveillance, demonstrating high accuracy (92%) and earlier detection of recurrence. These data support integration into post-treatment management to reduce diagnostic uncertainty and guide timely care.
Authors
- Laurie M. Gay (ORCID: https://orcid.org/0000-0003-2022-6130)
- Corbin D. Jacobs (ORCID: https://orcid.org/0000-0001-5717-1802)
- Iain MacEwan
- Ray Lin
- Shane Lloyd (ORCID: https://orcid.org/0000-0002-4235-7652)
- James Jabalee (ORCID: https://orcid.org/0000-0002-4266-0395)
- Stanley L. Liauw (ORCID: https://orcid.org/0000-0002-4701-2469)
- R. Kabarriti
- Gene-Fu Liu
- Sophia Y. Kim-Wang
- Chance Matthiesen
- Tiffany Juarez (ORCID: https://orcid.org/0000-0002-1736-9774)
- Jaswinder Singh
- T. F. Slater
- Sean Inocencio
- Kasha Neff
- Michael Rutenberg
- Alexandra H. Crawford
- Jennifer Ross
- Cammie Nguyen
- Kayleen Guzman
Institutions
- Albert Einstein College of Medicine (US)
- Scripps Health (US)
- Huntsman Cancer Institute (US)
- Scripps Mercy Hospital (US)
- WinnMed (US)
- University of Chicago (US)
- The University of Kansas Cancer Center (US)
- Cancer Care Northwest (US)
- Freeman Health System (US)
- Mayo Clinic in Florida (US)
- Mission Hospital (US)
Publication Details
- Journal
- Cancers
- Published
- 2025-12-22
- DOI
- https://doi.org/10.3390/cancers18010035
- Primary Topic
- Colorectal and Anal Carcinomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00